09/18/2023 TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
09/05/2023 TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences